Complete Filing Data
Polyrizon Ltd. reported Stockholders Equity of $20.99 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Polyrizon Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research And Development Expense | $2.1M | $534.0K | $332.0K | $347.0K |
| Operating Income Loss | -$6.2M | -$1.3M | -$635.0K | -$895.0K |
| Net Income Loss | -$3.3M | -$1.5M | -$600.0K | -$779.0K |
| General And Administrative Expense | $4.1M | $768.0K | $303.0K | $548.0K |
| Comprehensive Income Net Of Tax | -$1.5M | -$600.0K | -$779.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $21.0M | $5.3M | -$191.0K | -$900.0K | -$251.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.3M | $2.6M | $4.0K | $36.0K | $523.0K |
| Liabilities Fair Value Adjustment | $5.1M | -$211.0K | $293.0K | $118.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$1.2M | $2.6M | -$32.0K | -$487.0K | |
| Retained Earnings Accumulated Deficit | -$8.4M | -$5.1M | -$3.5M | ||
| Property Plant And Equipment Net | $12.0K | $10.0K | $12.0K | ||
| Other Assets Current | $396.0K | $99.0K | $13.0K | ||
| Liabilities Current | $443.0K | $261.0K | $502.0K | ||
| Liabilities And Stockholders Equity | $21.4M | $5.5M | $559.0K | ||
| Employee Related Liabilities Current | $149.0K | $45.0K | $39.0K | ||
| Cash And Cash Equivalents At Carrying Value | $1.3M | $2.6M | $4.0K | ||
| Assets Current | $12.9M | $2.7M | $54.0K | ||
| Assets | $21.4M | $5.5M | $559.0K | ||
| Accounts Payable And Accrued Liabilities Current | $294.0K | $216.0K | $158.0K | ||
| Intangible Assets Net Excluding Goodwill | $2.5M | $2.9M | |||
| Fair Value Of Assets Acquired | $8.0K | $17.0K | |||
| Derivative Liabilities Current | $105.0K | $398.0K | $516.0K | ||
| Repayments Of Convertible Debt | $316.0K | ||||
| Reclassification Of Warrant Liability To Equity | $316.0K | ||||
| Trading Securities Debt | $783.0K | ||||
| Temporary Equity Carrying Amount Attributable To Parent | $248.0K | ||||
| Stockholders Equity Note Subscriptions Receivable | $196.0K | ||||
| Short Term Investments | $37.0K | ||||
| Receivables On Account Of Shares | 3.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Proceeds From Issuance Of Common Stock | $266.0K | $105.0K | ||
| Share Based Compensation | $1.3M | $51.0K | $100.0K | $130.0K |
| Net Cash Provided By Used In Operating Activities | -$4.5M | -$1.1M | -$537.0K | -$1.1M |
| Net Cash Provided By Used In Financing Activities | $19.8M | $3.7M | $505.0K | $648.0K |
| Increase Decrease In Other Current Assets | $297.0K | $85.0K | -$2.0K | -$6.0K |
| Increase Decrease In Employee Related Liabilities | $104.0K | $6.0K | $2.0K | $19.0K |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $51.0K | $100.0K | $130.0K | |
| Net Cash Provided By Used In Investing Activities | -$16.5M | $29.0K | -$3.0K | |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $35.0K | $58.0K | $17.0K | |
| Increase Decrease In Deferred Charges | $14.0K | $354.0K | ||
| Proceeds From Convertible Debt | $310.0K | |||
| Payments To Acquire Property Plant And Equipment | $7.0K | $3.0K | ||
| Increase Decrease In Accrued Liabilities | $58.0K | $17.0K | -$15.0K | |
| Proceeds From Issuance Of Private Placement | $15.1M | |||
| Proceeds From Issuance Of Convertible Notes | $249.0K | $648.0K | ||
| Proceeds From Issuance Initial Public Offering | $4.7M | $3.4M | ||
| Stock Issued During Period Value Share Based Compensation | $1.3M | |||
| Proceeds From Sale Of Other Investments | $29.0K | |||
| Proceeds From Sale Of Investment In Shares | 29.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 680.4K | 2.0K | 1.4K | 1.3M |
| Weighted Average Number Of Diluted Shares Outstanding | 680.4K | 2.0K | 1.4K | 1.3M |
| Earnings Per Share Diluted | $4.90 | $805.20 | $494.40 | $0.60 |
| Earnings Per Share Basic | $4.90 | $805.20 | $494.40 | $0.60 |
| Common Stock Shares Outstanding | 1.6M | 2.8K | 2.6M | |
| Common Stock Shares Issued | 1.6M | 2.8K | 2.6M | |
| Common Stock Shares Authorized | 2.00B | 79.6K | 19.9M | |
| Preferred Stock Shares Outstanding | 0.00 | 104.7K | ||
| Preferred Stock Shares Issued | 0.00 | 104.7K | ||
| Preferred Stock Shares Authorized | 0.00 | 104.7K | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Financial Income Net | $2.9M | -$243.0K | $35.0K | $116.0K |
| Depreciation | $342.0K | $118.0K | $4.0K | $5.0K |
| Fair Value Revaluation In Convertible Notes | $25.0K | $228.0K | -$26.0K | |
| Additional Paid In Capital | $29.4M | $10.4M | $3.5M | |
| Stock Issued During Period Value New Issues | $266.0K | $310.0K | ||
| Stock Issued During Period Value Conversion Of Units | $225.0K | $899.0K | ||
| Conversion Of Stock Amount Converted1 | $225.0K | $899.0K | ||
| Stock Issued During Period Value Issued For Services | $6.5M | $2.9M | ||
| Adjustments To Additional Paid In Capital Warrant Issued | $316.0K | |||
| Stock Issued During Period Value Other | $3.0M | |||
| Stock Issued During Period Value Issued For Exerciseof Warrants | $11.2M | |||
| Stock Issued During Period Shares New Issues | 359.5K | |||
| Interest On Convertible Loans | $6.0K | |||
| IPO Warrants Exchange | $1.6M | |||
| Exercise Of Warrants Into Ordinary Shares | 11.2M | |||
| Conversion Of Convertible Notes Into Ordinary Shares | 225.0K | 899.0K | ||
| Stock Issued During Period Value Issuance Of Shares And Warrants Under Initial Public Offering Net | 2.9M | |||
| Stock Issued During Period Value Conversion Of Convertible Securities | $248.0K | |||
| Stock Issued1 | $54.0K |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.